Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recalcitrant pyoderma gangrenosum treated with thalidomide.

G L Federman1, D G Federman

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, CT 06516, USA.

Mayo Clinic Proceedings
|August 16, 2000
PubMed
Summary

Pyoderma gangrenosum, a painful skin ulcer, can be effectively treated with thalidomide. This study shows oral thalidomide healed a patient

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psoriasis: an opportunity to identify cardiovascular risk.

The British journal of dermatology·2008
Same author

Thrombosis: new culprits in an old disorder.

Panminerva medica·2002
Same author

Fatal rhabdomyolysis caused by lipid-lowering therapy.

Southern medical journal·2001
Same author

Cutaneous leishmaniasis in an Italian woman: case report.

Connecticut medicine·2001
Same author

Dermatology in primary care: Prevalence and patient disposition.

Journal of the American Academy of Dermatology·2001
Same author

Interpretation of cutaneous biopsy specimens: choice of pathologist by primary care practitioners.

Southern medical journal·2001

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Pyoderma gangrenosum is a severe, non-infectious skin ulceration.
  • It is often linked to underlying systemic inflammatory conditions.
  • Methylprednisolone is a common but sometimes ineffective treatment.

Observation:

  • A 47-year-old male patient presented with pyoderma gangrenosum.
  • The condition was histologically confirmed.
  • Previous treatments with methylprednisolone failed to induce healing.

Findings:

  • Oral thalidomide was administered for 10 weeks.
  • The patient's pyoderma gangrenosum ulcer completely healed.
  • Thalidomide demonstrated efficacy in this refractory case.

Implications:

  • Thalidomide represents a viable therapeutic option for refractory pyoderma gangrenosum.
  • This case highlights thalidomide's role in managing immune-modulated dermatologic diseases.
  • Further research into thalidomide for pyoderma gangrenosum is warranted.

Related Experiment Videos